Repligen
RGEN
#2270
Rank
HK$65.69 B
Marketcap
HK$1,167
Share price
-4.48%
Change (1 day)
-9.93%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: HK$65.69 Billion

As of February 2026 Repligen has a market cap of HK$65.69 Billion. This makes Repligen the world's 2270th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$65.69 B-9.76%
2025HK$72.79 B14.99%
2024HK$63.30 B-19.26%
2023HK$78.40 B6.74%
2022HK$73.45 B-35.67%
2021HK$114.17 B40.46%
2020HK$81.28 B116.66%
2019HK$37.51 B106.84%
2018HK$18.13 B46.88%
2017HK$12.34 B52.72%
2016HK$8.08 B11.92%
2015HK$7.22 B43.53%
2014HK$5.03 B49.06%
2013HK$3.37 B122.38%
2012HK$1.51 B83.44%
2011HK$0.82 B-26.33%
2010HK$1.12 B14.63%
2009HK$0.98 B7.62%
2008HK$0.91 B-42.57%
2007HK$1.58 B138.83%
2006HK$0.66 B-28.89%
2005HK$0.93 B38.75%
2004HK$0.67 B-33.63%
2003HK$1.01 B56.46%
2002HK$0.64 B28.07%
2001HK$0.50 B-27.68%
2000HK$0.69 B29.13%
1999HK$0.54 B203.32%
1998HK$0.17 B63.98%
1997HK$0.10 B-25.44%
1996HK$0.14 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Repligen was reported to be:

HK$65.69 Billion
by Nasdaq info icon info icon
HK$65.69 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.174 T 1,687.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$1.698 T 2,485.45%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$2.528 T 3,748.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$875.55 B 1,232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$1.40 B-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$11.22 B-82.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$105.98 B 61.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$78.01 B 18.77%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$84.86 B 29.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
HK$80.93 B 23.20%๐Ÿ‡บ๐Ÿ‡ธ USA